<SEC-DOCUMENT>0002024909-24-000002.txt : 20240913
<SEC-HEADER>0002024909-24-000002.hdr.sgml : 20240913
<ACCEPTANCE-DATETIME>20240913161257
ACCESSION NUMBER:		0002024909-24-000002
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240913
DATE AS OF CHANGE:		20240913

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioNTech SE
		CENTRAL INDEX KEY:			0001776985
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			2M
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-39081
		FILM NUMBER:		241297855

	BUSINESS ADDRESS:	
		STREET 1:		AN DER GOLDGRUBE 12
		CITY:			MAINZ
		STATE:			2M
		ZIP:			55131
		BUSINESS PHONE:		0049613190840

	MAIL ADDRESS:	
		STREET 1:		AN DER GOLDGRUBE 12
		CITY:			MAINZ
		STATE:			2M
		ZIP:			55131

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ATHOS KG
		CENTRAL INDEX KEY:			0001802897
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			2M
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		BERGFELDSTRASSE 9
		CITY:			HOLZKIRCHEN
		STATE:			2M
		ZIP:			83607
		BUSINESS PHONE:		0049802447059135

	MAIL ADDRESS:	
		STREET 1:		BERGFELDSTRASSE 9
		CITY:			HOLZKIRCHEN
		STATE:			2M
		ZIP:			83607
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001802897</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001776985</issuerCik>
      <issuerName>BioNTech SE</issuerName>
      <secFileNumber>001-39081</secFileNumber>
      <issuerAddress>
        <com:street1>AN DER GOLDGRUBE 12</com:street1>
        <com:city>MAINZ</com:city>
        <com:stateOrCountry>2M</com:stateOrCountry>
        <com:zipCode>55131</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>0049613190840</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>ATHOS KG</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>American Depositary Shares representing ordinary shares, no par value</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Berenberg Capital Markets LLC</name>
        <address>
          <com:street1>1251 Avenue of the Americas</com:street1>
          <com:street2>53rd Floor</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10020</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>170000</noOfUnitsSold>
      <aggregateMarketValue>19552584.00</aggregateMarketValue>
      <noOfUnitsOutstanding>237766235</noOfUnitsOutstanding>
      <approxSaleDate>09/13/2024</approxSaleDate>
      <securitiesExchangeName>NASD</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Ordinary Shares, no par value</securitiesClassTitle>
      <acquiredDate>01/05/2018</acquiredDate>
      <natureOfAcquisitionTransaction>Private placement</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>BioNTech SE</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>170000</amountOfSecuritiesAcquired>
      <paymentDate>01/05/2018</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>The filing of this Form 144 shall not be construed as an admission that the undersigned is an affiliate of the issuer. All ADS to be sold by AT Impf GmbH.</remarks>
    <noticeSignature>
      <noticeDate>09/13/2024</noticeDate>
      <signature>Berenberg Capital Markets LLC on behalf of /s/ Thomas Maier /s/ Stephan Sperber</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
